Table: Towa Pharmaceutical - 6-MTH group results

TOWA PHARMACEUTICAL

14/11/2022 06:00

Nov 14 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2022        Sep 30, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               90.50               82.25           196.40    
                   (+10.0 pct)         (+10.2 pct)      (+18.6 pct) 
  Operating            3.22               10.31             8.70    
                   (-68.8 pct)         (+15.7 pct)      (-54.7 pct) 
  Recurring            4.61               13.01            10.60    
                   (-64.6 pct)         (+46.9 pct)      (-53.4 pct) 
  Net                  2.69                9.24             6.30    
                   (-70.9 pct)         (+44.8 pct)      (-60.4 pct) 
  EPS               54.70 yen          187.79 yen       127.99 yen  
  EPS Diluted                          183.63 yen                   
  Ann Div                               60.00 yen        60.00 yen  
  -Q2 div           30.00 yen           27.00 yen                   
  -Q4 div                               33.00 yen        30.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T